Are you funding medtech? If you would like your firm added to our online directory this year and to next year’s resource guide, please email

890 Winter St, Ste 150
Waltham, MA 02451
fax: 781-466-8813

Key funding facts:
• Seeks long-term involvement with its investments.
• Invests in platform and enabling technologies, medical devices, and instrumentation, as well as companies developing therapeutics and healthcare services businesses.
• Invests in early and late-stage venture, growth equity, and public markets.
• Invests $20 million-$80 million; monies may be invested over more than one round of financing.

Past and/or current medtech investment:
• Epigenomics is developing oncology diagnostics based on DNA methylation patterns.
• Lombard Medical Technologies is focused on developing solutions for the $1.1 billion abdominal aortic aneurysm (AAA) repair market.

Advanced Technology Ventures
485 Ramona St
Palo Alto, CA 94301
fax: 650- 321-0934
500 Boylston St, Ste 1380
Boston, MA 02116
fax: 617-850-9750

Key funding facts:
• Healthcare is one of three core technology markets for the firm. (The firm also funds IT and cleantech.)
• Has more than $1.6 billion to fund new ideas.

Past and/or current medtech investment:
• Altura Medical, Inc is an early-stage medical device company focused on innovative devices and methods for the percutaneous treatment of abdominal aortic aneurysms.
• Ardian (acquired by Medtronic) develops catheter-­based therapies to treat hypertension and related conditions.
• GluMetrics is developing a hospital-use glucose monitoring device for patients in intensive care units.
• MicroVention (acquired by Terumo) is a rapidly growing medical device company that is pioneering the development of catheter-based technologies for the endovascular treatment of peripheral and cerebral vascular diseases.

Alta Partners
One Embarcadero Center, 37th Fl
San Francisco, CA 94111
fax: 415-362-6178

Key funding facts:
• Funded more than 145 life science companies since 1996.
• Prefers to act as lead investor in the projects it pursues and, when appropriate, takes a board seat as part of its investment.
• Looks for companies developing unique and proprietary products or technologies, which provide a barrier to competition through technological dominance or a strong intellectual property.
• Seeks companies that target large, compelling market opportunities and entrepreneurial teams driven to succeed.

Past and/or current medtech investment:
• Bioventus (Smith & Nephew’s former Biologics Division/Clinical Therapies business) develops an ultrasound bone healing system and hyaluronic acid joint fluid therapy products that treat the symptoms of osteoarthritis.
• Carbylan BioSurgery is developing bioresponsive medical products for osteoarthritis and chronic rhinosinusitus.
• Insulet is commercializing the OmniPod Insulin Management System for diabetes patients
• Vertiflex is developing a line of proprietary products focused in the area of motion preservation with an emphasis on minimally invasive approaches.

Apax Partners
601 Lexington Ave, 53rd Fl
New York, NY 10022
fax: 212-319-6155

Key funding facts:
• Invested more than €2.9 billion in the past 10 years in healthcare companies across multiple geographies, including the US, Europe, and Asia.

Past and/or current medtech investment:
• KCI provides therapies and products for the advanced wound care, tissue regeneration, and therapeutic support system markets.
• Molnlycke Health Care develops surgical care and wound-care products.

Audax Group
101 Huntington Ave
Boston, MA 02199
fax: 617-859-1600

Key funding facts:
• Acquires controlling interests in small cap and lower-middle market companies.
• Invests equity of $10 million to $100 million in transactions valued between $15 million and $250 million.
• Companies should meet at least one of the following criteria: at least $5 million of EBITDA; ability to reach $5 million of EBITDA within 12 months; under­performing with at least $50 million of revenue; strategic add-on of any size.

Past and/or current medtech investment:
• Denver Biomedical manufactures, distributes, and markets of medical devices for fluid management in the chest and abdomen.
• Laborie Medical Technologies, Inc provides urodynamic testing equipment and consumables for urinary incontinence.

Bain Capital Ventures
200 Clarendon St
Boston, MA 02116
fax: 617-516-2010/p>

Key funding facts:
• Invests across all stages of a company’s growth, from seed capital through late stage growth equity and growth buyouts.
• Manages approximately $2 billion of committed capital.
• Investments range from several hundred thousand dollars of seed capital up to $50 million of growth equity capital.

Past and/or current medtech investment:
• Boston Heart Diagnostics’ diagnostics assess the patient’s health as part of a comprehensive CVD risk profile.
• EyeTel Imaging (acquired by Neurometrix) manufactures a digital retinal imaging device.
• Nanosphere offers proprietary breakthrough technologies that provide a unique and powerful solution to greatly simplify diagnostic testing.

Baird Venture Partners
777 East Wisconsin Ave
Milwaukee, WI 53202

Key funding facts:
• Focuses on early- and expansion-stage companies with experienced management teams and innovative, capital-efficient business models.
• Provides capital for new services, products, geographic expansion and acquisitions.

Past and/or current medtech investment:
• Celleration, Inc has developed a proprietary device utilizing therapeutic noncontact ultrasound technology for treatment of chronic and recalcitrant dermal wounds.
• CoAxia, Inc is pioneering the use of catheter-based perfusion augmentation systems for the treatment of cerebral ischemia.
• Core Essence Orthopaedics, Inc is focused in arthroscopic and endoscopic small bone and soft tissue repair.
• Veniti, Inc is a growing medical device company focused on treating chronic venous disease.

Bay City Capital
750 Battery St, Ste 400
San Francisco, CA 94111
fax: 415-837-0503

Key funding facts:
• Managed eight venture funds representing over $1.6 billion in capital invested in more than 90 companies worldwide. Five of these funds are general life sciences funds, and three are sector funds.
• Pursues a broad spectrum of investment opportunities across the various life sciences sectors.
• Invests in companies at all stages of development.
• Invests in life sciences companies where its operational, financial, and scientific expertise can benefit company management.
• Investments have ranged from seed investing to early, mid-, and late-stage, as well as select public investing.

Past and/or current medtech investment:
• Enteromedics develops therapeutic devices for the treatment of obesity.
• IDEV develops next-generation medical devices for use in interventional radiology, vascular surgery, and cardiology, including a new class of self-expanding nitinol stent system.
• Nevro markets novel neuromodulation therapies for the treatment of chronic, intractable pain.

Canaan Partners
2765 Sand Hill Rd
Menlo Park, CA 94025
fax: 650-854-8127

Key funding facts:
• When possible, contact the firm through a personal referral.
• Invests in novel, next-generation devices to treat major diseases; devices that target chronic diseases and diseases of aging; companies pursuing therapies that are less-invasive than current approaches; strong consumer demand for therapies.

Past and/or current medtech investment:
• Calibra is developing medical devices and technologies designed to make insulin therapy easier and more discreet.
• Coapt Systems soft tissue fixation technology enables surgeons to reliably place and shape soft tissue during reconstructive procedures.
• Relievant develops devices to address chronic back pain.
• Transcend is focused on treating glaucoma with a minimally invasive procedure that is effective, well-tolerated, and safe.

CMEA Capital
1 Letterman Dr
Bldg C, Ste CM500
San Francisco, CA 94129
fax: 415-352-1524

Key funding facts:
• Invests in drug-development, medical device, and diagnostics companies that can rapidly prove their concept, and efficiently use capital.
• Invests in companies where the investment will inject significant value within 30 months.

Past and/or current medtech investment:
• Baxano, Inc is focused on developing minimally invasive tools to restore spine function and preserve healthy tissue.
• BioMimetic Therapeutics, Inc is developing regenerative protein-device combination products for the healing of musculo­skeletal injuries and disease, including orthopedic and spine.
• SurgiQuest, Inc develops, manufactures, and markets innovative technology for minimally invasive surgery.
• VeraLight focuses on a comprehensive approach to noninvasive diabetes and pre-diabetes screening.

DW Healthcare Partners
1413 Center Dr, Ste 220
Park City, UT 84098
fax: 435-645-4065

Key funding facts:
• Invests exclusively in healthcare companies.
• Investment criteria includes $4 million EBITDA and above; strong historical growth rates; North American companies; majority ownership preferred (may consider minority); equity investment $10+ million.

Past and/or current medtech investment:
• ABC Home Medical Supply provides catheters and other urological products to customers with chronic medical diagnoses such as spinal cord injuries, spina bifida, multiple sclerosis, and transverse myelitis.
• Arteriocyte Medical Systems manufactures cellular therapy products in the cardiac, orthopedic, and vascular surgery market.
• Verathon develops a noninvasive bladder volume instrument and video ­laryngoscope.
• Z-Medica develops, manufactures, and markets innovative hemostatic agents.

Flexpoint Ford
335 Bryant St, 3rd Fl
Palo Alto, CA 94301
fax: 650-327-9755

Key funding facts:
• Currently has $2.5 billion under management.
• Investing out of its eighth fund of $900 million, which closed in 2009.
• Majority of capital allocated to growth equity with a minority targeted toward traditional venture capital investments.
• Investment practice includes seed, late venture, growth equity, PIPE, and buyout financings, with a majority of capital geared toward the latter three.

Past and/or current medtech investment:
• Abiomed produces the world’s smallest, minimally invasive, high-performance micro blood pump with integrated motors and sensors.
• Bioform Medical produces injectable implant products used in minimally invasive soft tissue augmentation procedures.
• MicroMed develops a ventricular assist device as bridge to heart transplant.
• Orthovita makes orthopedic surgical biomaterials for advanced bone regeneration and soft tissue healing.

Frazier Healthcare
601 Union, Two Union Square, Ste 3200
Seattle, WA 98101
fax: 206-621-1848

Key funding facts:
• Takes an opportunistic approach to medical device investing
• Focuses venture allocation on companies that are developing biopharma therapeutics that have the potential for near-term revenue in large markets and/or prerevenue exits.

Past and/or current medtech investment:
• Ascension Orthopedics is addressing unmet needs in the extremeties field.
• Barosense is developing trans-oral medical devices and procedures for addressing obesity and its co-morbidities.
• Calibra Medical is developing a mechanical disposable insulin pump.
• InnerPulse is developing a disruptive interventional technology platform for cardiac rhythm management devices.
• Primaeva (acquired by Syneron) is an early-stage company developing a skin tightening and rejuvenation dermatological device.

Highlander Partners LP
3811 Turtle Creek Blvd, Ste 250
Dallas, TX 75219
fax: 214-245-5015

Key funding facts:
• Seeks to provide private direct equity or mezzanine financing to companies with sales of $10 million to $500 million, exceptional growth prospects and strong, stable market positions.
• Targets opportunistic equity and mezzanine investments in middle market companies.
• Over $400 million committed to direct private equity investments.
• Manages proprietary capital, not capital provided by outside institutions or individuals.

Past and/or current medtech investment:
• Pioneer Surgical Technology, Inc manufactures spinal and orthopaedic implants and instruments.

Kaiser Permanente Ventures
One Kaiser Plaza, 22nd Fl
Oakland, CA 94612
fax: 510-891-7943

Key funding facts:
• Partners with entrepreneurial teams. No other guidance published on web site.
Past and/or current medtech investment:
• AtheroMed develops a medical device for treatment of peripheral artery disease.
• Transcend Medical develops a device for treatment of glaucoma.
• Trivascular makes an endovascular stent graft system.
• Valeritas makes a disposable insulin delivery device for Type II diabetes.
• Zonare develops a compact and portable ultrasound solutions.

Life Sciences Greenhouse of Central Pennsylvania
225 Market St, Ste 500
Harrisburg, PA 17101

Key funding facts:
• Provides investment funding up to $1 million in milestone-driven convertible debt or equity financing.
• Invests in viable seed-stage or established life sciences companies that have significant potential for commercial growth.
• Encourages both established and formational companies to apply, provided they emphasize the life sciences and have staffing commitments to central Pennsylvania.

Past and/or current medtech investment
• Apeliotus Vision Science is developing a simple, cost-effective diagnostic tool for the early detection of age-related macular degeneration.
• INRange Systems, Inc has developed a remote medication management technology.
• Micro Interventional Devices, Inc (MID) is developing solutions to address unmet needs in structural heart repair procedures.
• Saladax Biomedical develops novel diagnostic assays for the practical delivery of personalized medicine.

Linden LLC
111 S. Wacker Dr, Ste 3350
Chicago, IL 60606
fax: 312-506-5601

Key funding facts:
• Purchases controlling equity interests in privately held companies and non-core businesses that can benefit from strategic redirection, operational improvements, acquisitions, and additions to the management team.
• Invests primarily in leveraged buyouts or other late-stage transactions where it can be the lead investor or otherwise have significant governance influence.

Past and/or current medtech investment:
• AbilityOne designs, develops, and manufactures products to aid physical rehabilitation following injuries, illnesses, and orthopedic procedures and other forms of surgery.
• HYCOR manufactures and markets high-quality diagnostic products used in clinical laboratories throughout the world to test for a range of medical disorders.
• MedSystems develops, manufactures, and markets innovative medical devices focused on enteral feeding and bedside location technologies for critically ill patients.

Mohr Davidow Ventures
3000 Sand Hill Rd, 3-290
Menlo Park, CA 94025
fax: 650-854-7365

Key funding facts:
• Usually the first institutional investors, but also makes seed stage investments.
• Works best with entrepreneurs who welcome its commitment and involvement as well as its funding; those whose vision and sense of mission is both compelling and pragmatic.

Past and/or current medtech investment:
• Corventis enables early detection of cardiovascular events while allowing patients to maintain an active lifestyle by combining medical device, wireless, and information technologies.
• DVS Sciences, Inc produces and markets a high throughput mass cytometer for individual cell analysis and a system of reagents related to massively multi-parametric assays.

Morgenthaler Ventures
2710 Sand Hill Rd, Ste 100
Menlo Park, CA 94025
fax: 650-388-7601

Key funding facts:
• Invests in a broad spectrum of life science companies, particularly those in the fields of therapeutic biopharmaceuticals and medical devices.
• Expects to invest between $12 million and $20 million total in a biotech company over several rounds; and between $10 million and $12 million for a device company.
• Majority of investments have been in Series A, but the firm is open to later-stage opportunities.

Past and/or current medtech investment:
• AneuRx (acquired by Medtronic) develops stent grafts for abdominal aortic aneurysm.
• Cardiomind, Inc develops stents for small diameter and distal hard-to-reach coronary vessels.
• Embol-X (acquired by Edwards Lifesciences) makes devices to protect the brain from stroke.
• Kona Medical develops a novel, non­invasive technology for the treatment of hypertension.
• SetPoint Medical makes a neuromodulation platform for the treatment of a variety of acute and chronic diseases.
• Vertiflex develops implantable devices to treat chronic spinal disorders.

New Enterprise Associates (NEA)
2855 Sand Hill Rd
Menlo Park, CA 94025
fax: 650-854-9397

Key funding facts:
• Focuses on biopharmaceuticals, healthcare services/IT, and medical devices.
• Partners with companies that have pioneered transformative innovations in healthcare, such as balloon angioplasty and laparoscopic surgery.
• Spans all stages of a company’s growth, from seeding innovations in emerging markets to funding early-stage companies in high-growth markets to fueling the growth of market leaders.
• Majority of companies backed are early-stage investments.

Past and/or current medtech investment:
• Acclarent, Inc (acquired by Ethicon, Inc) develops balloon sinuplasty and other innovative device-based treatments for ENT specialists and their patients.
• Acoustic Imaging Technologies Corp (acquired by Dornier) makes high-resolution, medical ultrasound imaging systems.
• Advanced Cardiovascular Systems (acquired by Eli Lilly & Co) develops balloon angioplasty catheter systems.
• Apnex Medical, Inc develops innovations to improve the health of people with sleep-disordered breathing.
• BridgePoint Medical, Inc makes devices to recanalize chronic total occlusions.
• Minerva Surgical, Inc is a medical device start-up company focused on women’s healthcare.
• Solace Therapeutics develops nonsurgical office based treatments for common bladder disorders.
• TransVascular, Inc (acquired by Medtronic) develops a new class of intervention for the treatment of vascular diseases and other disorders.

Physic Ventures
200 California St, 5th Fl
San Francisco, CA 94111
fax: 415-354-4915

Key funding facts:
• Invests in solutions that engage and empower people to improve their health and well-being.
• Looks for science and technology-based innovations that improve health delivery, create access to new health management tools, improve diagnosis and prevention of chronic disease, and enable people to lead healthier lives.
• Invests in seed to growth equity stage companies located primarily in North America with global market potential.
• Partners with companies building prevention, personalization, participation, performance, transparency, efficiency, and connectivity.

Past and/or current medtech investment:
• On-Q-ity is a next-generation diagnostics company focused on transforming cancer.
• T2 Biosystems is creating a universal platform to enable rapid, accurate, easy-to-use diagnostics in the decentralized setting.

Psilos Group Managers, LLC
140 Broadway, 51st Fl
New York, NY 10005
fax: 212-242-8855

Key funding facts:
• Over 10 years experience with prior professional relationships that span up to 20 years in the healthcare field.
• Invests in the healthcare services, healthcare information technology, and medical technology (devices and diagnostics) sectors.
• Invests in companies that deploy new technologies and delivery models that overcome traditional barriers to adoption and that actively align the incentives, financial and clinical, of patients, payers, and providers.

Past and/or current medtech investment:
• AngioScore, Inc. develops, manufactures and markets the AngioSculpt Scoring Balloon Catheter for both coronary and peripheral interventions.
• BioVentrix, Inc. develops advanced solutions that provide new pathways to treat heart failure patients.
• Endoscopic Technologies develops and sells products for use in minimally invasive cardiovascular surgery applications.
• Gamma Medica-Ideas (GMI) develops, manufactures, and markets fully digital medical imaging systems that improve patient health through early diagnosis of disease, improved patient treatment and by enabling new drug discovery.
• OmniGuide Corp makes and markets the world’s most precise optical scalpels for minimally invasive surgery.
• SmartPill Corp develops and manufactures ingestible, capsule-based medical devices that aid in the diagnosis, definition, and therapeutic intervention of gastrointestinal disorders and diseases.
• VeraLight is developing the SCOUT DS, the first noninvasive diabetes screening system to provide a more accurate and convenient method for screening type 2 diabetes and pre-diabetes.
• Verium’s proprietary diagnostic scan (CERSR) enables physicians to isolate the source of chronic low back pain and prescribe targeted physical therapy for dramatically improve outcomes at lower cost.

Roundtable Healthcare Partners
272 East Deerpath Rd, Ste 350
Lake Forest, IL 60045
fax: 847-482-9215

Key funding facts:
• Manages five investment funds, which total $1.9 billion of capital under ­management.
• Seeks opportunities where its expertise makes it a differentiated, value-added partner.

Past and/or current medtech investment:
• Argon Medical Devices, Inc manufactures and supplies specialty single-use vascular interventional and pressure monitoring devices utilized in the cardiology, radiology, and critical care market segments.
• Beaver-Visitec International develops, manufactures, and markets specialized surgical devices for the ophthalmic market place.
• Excelsior Medical has a primary focus on innovative catheter maintenance products.

Safeguard Scientifics
435 Devon Park Dr, Bldg 800
Wayne, PA 19087
fax: 610-293-0601

Key funding facts:
• Deploys capital into companies that are operating in large, growing markets; that have barriers to entry by competitors, such as proprietary technology and intellectual property, or other competitive advantages; and that have a compelling growth strategy.
• Generally participates as the primary shareholder in each partner company
• Works with a strong network of syndication partners.
• Deploys up to $25 million in growth capital per partner company over the lifecycle of its partnership.
• The most promising growth-stage life sciences and technology companies have innovations that address one or more of these five key strategic themes within their marketplace: maturity, migration, convergence, compliance, and cost containment.
• Participates in expansion financings, corporate spin-outs, management buyouts, recapitalizations, industry consolidations and early-stage financings.

Past and/or current medtech investment:
• Alverix produces novel, handheld and pocket-sized medical diagnostic instruments.
• Crescendo Bioscience is a molecular diagnostics company focused in rheumatology.
• Good Start Genetics is a molecular diagnostic company that has developed more accurate and comprehensive prepregnancy genetic tests based on proprietary gene-sequencing technology.
• NovaSom provides diagnostic devices and services for home testing and evaluation of sleep-disordered breathing.
• PixelOptics developed and has begun to commercialize the world’s first and only electronically focusing prescription eyewear.

Scale Venture Partners
950 Tower Lane, Ste 700
Foster City, CA 94404
fax: 650-378-6040

Key funding facts:
• Invests in high-growth technology companies.
• Looks for companies that are in early revenue and are ready to scale.
• Investments often range from $3 million to $20 million, with an average of about $12 million over the life of an investment.
• Always takes a board or observer seat in its portfolio companies.
• Invests in companies that have the most potential to realize sustainable profitability and success through a trade sale or IPO.

Past and/or current medtech investment:
• Oraya Therapeutics develops noninvasive, robotically controlled treatments for inflammatory and neovascular diseases of the eye.
• Spinal Kinetics focuses on partnering with spine surgeons to develop innovative and practical motion preservation systems for treating degenerative diseases of the spine.

Siemens Venture Capital­inancialservices/venturecapital/pages/venture_capital.aspx
801 Boylston St
Boston, MA 02116

Key funding facts:
• Identifies and finances young companies worldwide during their start-up phase.
• Provides established companies with additional capital for their growth plans during the expansion phase.
• Invests in companies that have the most potential to realize sustainable profitability and success—through a trade sale or IPO.
• Invests in companies that have a sustainable advantage in an attractive market, have technology that has been proven in the field, have referenceable customers, have the desire to scale their businesses.
• Less focused on a specific revenue number; but more interested in market traction, leadership, momentum, and potential market opportunity.

Past and/or current medtech investment:
• Chemclin develops radioimmunoassay, ELISA, and chemiluminescent kits.
• Cylex is a life science company and a leader in the development and manufacture of unique products that use the immune system for predicting and managing human health.
• U-Systems, Inc develops ultrasound systems to assist radiologists in the diagnosis of breast cancer.
• ViewRay is in the process of developing an MRI-guided radiotherapy system.
• Zonare Medical Systems, Inc designs, develops, and manufactures high-­performance ultrasound solutions, which combine revolutionary technology with an innovative physical design.

Summit Partners
222 Berkeley St, 18th Fl
Boston, MA 02116
Fax: 617-824-1100

Key funding facts:
• Since 1984, provided growth equity and credit to more than 65 healthcare and life sciences companies.
• Built many category-leading companies within a variety of subsectors, including practice management, home health, information technology, and clinical and pathology laboratories.
• More than 40 public offerings and strategic mergers in the healthcare and life sciences industry.
• Offers equity and credit financing that can be used to achieve company growth, shareholder liquidity, recapitalizations, and management buyouts.
• Invests as little as $5 million to more than $500 million per company from equity and credit funds.

Past and/or current medtech investment:
• ApoCell Inc is a specialized molecular diagnostics laboratory.
• Aurora Diagnostics is a specialized anatomic pathology laboratory.
• IMMCO Diagnostics provides autoimmune diagnostic products and
• LiteCure LLC develops bio-photonic instruments and medical lasers.

SV Life Sciences
One Boston Place
201 Washington St, Ste 3900
Boston, MA 02108
fax: 617-367-1590

Key funding facts:
• Manages five private venture capital funds with approximately $2 billion of capital under management.
• Employs a diversified strategy within life sciences in order to selectively capitalize on an expanding opportunity in biotech, medical devices, and healthcare services.

Past and/or current medtech investment:
• AcuFocus is developing an implantable corneal in-lay for the correction of presbyopia.
• Altura is developing a low-profile stent graft for the treatment of abdominal aortic aneurysms (AAA).
• Cardiomind has developed an innovative stent and stent delivery system for small, difficult-to-access vessels.
• Cerebral Vascular Applications (TIF Company) has developed a set of minimally invasive tools for atrial appendage sealing for stroke prevention.
• MicroMed has developed an implantable pump for use as a left ventricular assist device (LVAD) to aid the heart’s pumping action in patients suffering from congestive heart failure.

Thomas, McNerney & Partners
One Stamford Plaza
263 Tresser Blvd, Ste 1600
Stamford, CT 06901
fax: 203-978-2005

Key funding facts:
• Invests in life science and medical technology companies at all stages of development.
• Significant experience in helping entrepreneurs start companies, in providing growth capital to emerging companies, and in undertaking restructuring transactions such as spin-outs, roll-ups, and recapitalizations.
• Approximately $600 million under management focused on investing in life science and medical technology companies.
• Continuing to make new investments from a $375 million fund that closed in August 2006.
• Targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors as well as in other areas that utilize medical technology innovation.
• Companies raising growth capital for product commercialization or developing therapeutic products for indications with high unmet medical need are of particular interest.

Past and/or current medtech investment:
• Aksys, Ltd developed an automated personal hemodialysis system for patient-performed hemodialysis in alternative care settings such as the patient’s home.
• American Medical Systems Holdings, Inc (acquired from Pfizer Inc) manufactures and markets devices to surgically treat incontinence and impotence.
• Epicor Medical, Inc develops devices for the treatment of atrial fibrillation (acquired by St. Jude Medical).
• Image-Guided Neurologics, Inc develops and markets devices to improve the accuracy of, and reduce the time required for, image-guided neurosurgery (acquired by Medtronic).
• Wright Medical Group, Inc manufactures and markets a full line of orthopedic implants with leading shares of the small joint replacement and biologically active bone void filler markets.

Tullis Health Investors
One Stamford Plaza
263 Tresser Blvd, 12th Fl
Stamford, CT 06901

Key funding facts:
• Manages a family of private equity funds, each focused exclusively on healthcare.
• Invests in all major areas of the health care industry.
• Provides equity and equity-related capital to small and emerging health care companies.
• Focuses on companies that have already established operations or have completed a substantial portion of their development process for new products, technologies, and services.

Past and/or current medtech investment:
• Vidacare manufactures and markets advanced intraosseous access technology for multiple diagnostic, monitoring and therapeutic applications.

Vantage Point Venture Partners
1001 Bayhill Dr, Ste 300
San Bruno, CA 94066
fax: 650-869-6078

Key funding facts:
• Supplies portfolio companies capital as well as guidance in finance, human capital, legal, marketing, science, and portfolio management.
• Provides cutting-edge technology companies with the resources to commercialize big opportunities.
• Supports portfolio companies from start-up through scale-up.
• Over $4 billion of committed capital and has made substantial investments in energy, information technology, internet and digital media, healthcare, and Asia.

Past and/or current medtech investment:
• Conceptus makes the first proven minimally invasive form of permanent birth control.
• Direct Flow Medical is a next-­generation, minimally invasive implant to treat patients with heart valve disease.

55 Cambridge Pkwy, Ste 100
Cambridge, MA 02142
fax: 617-995-2001

Key funding facts:
• Primary focus on technology, healthcare, and energy.
• Healthcare IT investments span more than a decade.

Past and/or current medtech investment:
• Advance Medical is a commercial-focused company whose mission is to become the partner-of-choice for innovative global medical technology companies looking to commercialize their products in Latin America.
• Ariosa Diagnostics has developed, and is currently commercializing, a proprietary noninvasive prenatal diagnostic test for genetic abnormalities.
• Mevion Medical Systems, Inc (formerly Still River Systems, Inc) is a radiation therapy company dedicated to advancing the treatment of cancer.
• PowerVision is developing a proprietary fluid-controlled accommodating intraocular lens technology that it believes will restore the vision of youth to millions of middle-aged or elderly individuals.

Versant Ventures
3000 Sand Hill Rd, Bldg 4, Ste 210
Menlo Park, CA 94025
fax: 650-854-9513

Key funding facts:
• Focus is medical devices, biopharmaceuticals, and other life sciences opportunities.
• Has $1.6 billion under management and is currently investing $500 million fund raised in July 2008.
• Initial investments have been as small as $250,000 and total investments have been as large as $30 million.
• Invests throughout the United States and in Western Europe.

Past and/or current medtech investment:
• AcuFocus is developing a corneal implant to treat presbyopia (the need for reading glasses).
• Autonomic Technologies is developing an implantable neuromodulation system for patients suffering from migraines and other severe headaches.
• Respicardia is developing an implantable system to treat central sleep apnea in patients with heart failure.
• Sequent Medical is developing a novel device for the treatment of cerebral aneurysm.
• Zyga is developing and marketing innovative, minimally invasive surgical solutions to treat conditions of the spine.

Vestar Capital Partners
245 Park Ave, 41st Fl
New York, NY 10167

Key funding facts:
• Invests in companies that primarily range in value from $150 million to $1.5 billion.
• Typically companies are among the leaders in their category, with well-­established products, services and brands.
• Looks for management partners who have a proven track record in building a company and a clear vision for taking that company to the next level.

Past and/or current medtech investment:
• DeVilbiss manufactures respiratory and sleep products that address the needs of patients in institutional and home care settings.
• Joerns Healthcare offers a variety of medical products, such as beds, lifts, and slings, and wound-prevention and treatment products.
• Sunrise Medical manufactures assistive-­technology devices that address recovery, rehabilitation, and mobility needs.

Welsh, Carson, Anderson & Stowe
320 Park Ave, Ste 2500
New York, NY 10022-6815
fax: 212-893-9575

Key funding facts:
• Invests in growth-oriented companies within the healthcare and information/business services industries.
• Investment strategy is deal size agnostic.
• Focuses on producing capital gains and attractive investment multiples in addition to strong internal rates of return.

Past and/or currentmedtech investment:
• AGA Medical manufactures heart and vascular defects devices.
• Bausch & Lomb manufactures ophthalmic products.
• K2M manufactures spine surgery products used to treat spine disorders.
• Valeritas manufactures an FDA-approved disposable insulin delivery device.